Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae
Author(s) -
Tomoko MoritaIshihara,
Magnus Unemo,
Keiichi Furubayashi,
Takuya Kawahata,
Ken Shimuta,
Shuichi Nakayama,
Makoto Ohnishi
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku118
Subject(s) - neisseria gonorrhoeae , mtrr , multilocus sequence typing , microbiology and biotechnology , biology , azithromycin , etest , spectinomycin , antibiotic resistance , cefpodoxime , multiple loci vntr analysis , virology , cephalosporin , genetics , antimicrobial , genotype , antibiotics , variable number tandem repeat , gene , methylenetetrahydrofolate reductase
Antimicrobial resistance in Neisseria gonorrhoeae is a major public health concern globally. We report the first verified treatment failure of gonorrhoea with 2 g of azithromycin (extended-release formulation) in Japan and characteristics of the corresponding N. gonorrhoeae isolates.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom